Conference: Brain Iron Accumulation in Neurological Diseases & Its Removal by Iron Chelation

Brain Iron Accumulation in Neurological Diseases & Its Removal by Iron Chelation
(London Iron Metabolism Group)

Wednesday 21st May 2014 14:00-18:30

King’s College London
Franklin Wilkins Building, Classroom 3.52,
Stamford Street, London. SE1 9NH

Chairs: A McKie & D. Dexter

Program

14:00-14:30 David Dexter (Imperial College London, UK)
A pilot efficacy and safety study with Deferiprone in Parkinson’s disease.

14:30-15:00 Joanna Collingwood (University of Warwick, UK)
Iron determinations in post-mortem brain and utilising MRI in Parkinson’s related disorders.

15:00-15:30 David Devos (Lille University, France)
Targeting chelatable iron as a therapeutic option in the treatment of Parkinson’s Disease.

15:30-16:00 Tea

16:00-16:30 John Connelly & Michael Spino (ApoPharma Inc, Canada)
The hydroxypyridinone dosing dilemma in neurodegeneration.

16:30-17:00 James Duce (University of Leeds, UK)
Role of APP in iron metabolism and neurodegeneration.

17:00-17:30 Kailash Bhatia (Institute of Neurology, University College London, UK)
Pathophysiology of neurodegeneration with brain iron accumulation (NBIA).

18:00 General Discussion

To reserve your place please contact: Andy McKie (Andrew.mckie@kcl.ac.uk)

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

One Response to “Conference: Brain Iron Accumulation in Neurological Diseases & Its Removal by Iron Chelation”

  1. Vlad says:

    Small iron in humans – is bad, a lot of iron in man – bad))))

Leave a Reply

*